Comunicaciones en congresos
Enhanced Documentation of Capecitabine Adherence in Stage II–III Colorectal Cancer: A Quality Improvement Initiative at the University Hospital of Navarra
ASCO Quality Care Symposium, October 10 – 11, 2025, Marriott Marquis Chicago, Chicago IL, USA.
This initiative focused on improving the documentation of capecitabine adherence in stage II–III colorectal cancer by combining multidisciplinary interventions, staff training, EHR updates, and patient education to support systematic monitoring of treatment adherence.
Quality Improvement Project to Optimize the Management of Immune-Related Toxicity in Hospitalized Patients Receiving Immunotherapy
ASCO Quality Care Symposium, October 10 – 11, 2025, Marriott Marquis Chicago, Chicago IL, USA.
This project aimed to optimize the management of immune-related adverse events in hospitalized patients receiving immunotherapy through structured interventions, including pre-treatment immunology consultations, oncologist training, and staff education, to enhance patient care.
Analysis of the Clinical Impact of the Time to Reimbursement of New Oncology Drugs in Spain: A Case Study in Breast Cancer
ISPOR Congress, November 17-20 2024, Barcelona, Spain.
These analysis provide possible metrics to quantify the benefits of minimizing time through better coordination of all the agents involved in the different phases leading to the availability of the drug in the healthcare system.
Precision Medicine in Spain: A Real-World Study on Biomarker Testing Rates across Spanish Regions
ISPOR Congress, November 17-20 2024, Barcelona, Spain.
This study showcases that even if there is an extensive adoption of precision medicine in Spain, testing rate is far from 100% in most of the populations in scope, in addition to the existence of variations across different regions in the country.
Mejora de la Calidad Asistencial en los Hospitales Españoles Comprometidos con el Programa QOPI
XIII Jornadas Nacionales SEDISA, May 22-24, 2024, Valencia, Spain.
Este estudio evalúa las puntuaciones de QOPI® en España, mostrando mejoras en los registros clínicos y la calidad asistencial, así como áreas que requieren más trabajo. La Fundación ECO continuará apoyando a los hospitales para mejorar la atención oncológica en España.
Quality Recommendations for the Management of Cutaneous Squamous Cell Carcinoma (cSCC)
NCCN 2023 Annual Conference, March 31 to April 2, 2023, San Francisco, USA.
In response to the existing gaps and questions within current clinical guidelines, recommendations addressing 29 clinical questions were formulated by this scientific committee for the management of patients with cSCC.
The committee reviewed MTBs in Spain, identified improvement areas, and compiled recommendations. This report supports proposing MTB committee accreditation to enhance healthcare quality and outcomes for patients.
Assessing and Accrediting Molecular Tumor Boards in Spain. (MTBs Excellence)
The committee assessed MTBs in Spain, identifying areas for improvement and compiling a report with recommendations. This report formed the basis for proposing the accreditation of MTB committees, with the aim of improving healthcare quality and outcomes for eligible MTB patients.
Assessing and Accrediting Molecular Tumor Boards in Spain. (MTBs Excellence)
The committee assessed MTBs in Spain, identifying areas for improvement and compiling a report with recommendations. This report formed the basis for proposing the accreditation of MTB committees, with the aim of improving healthcare quality and outcomes for eligible MTB patients.